Ten SNPs in genes within the cholesterol-lowering pathway modify the effectiveness of statins in reducing the risk of myocardial infarction

被引：0
|
作者：
Peters, W. M.
Pett, H.
Klungel, O. H.
机构：
来源：
PHARMACOGENOMICS | 2012年 / 13卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：18 / 18
页数：1
相关论文
共 9 条
  • [1] Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI
    Peters, Bas J. M.
    Pett, Helmi
    Klungel, Olaf H.
    Stricker, Bruno H. Ch.
    Psaty, Bruce M.
    Glazer, Nicole L.
    Wiggins, Kerri L.
    Bis, Josh C.
    de Boer, Anthonius
    Maitland-van der Zee, Anke-Hilse
    ATHEROSCLEROSIS, 2011, 217 (02) : 458 - 464
  • [2] Variants of ADAMTS1 modify the effectiveness of statins in reducing the risk of myocardial infarction
    Peters, Bas J. M.
    Rodin, Andrei S.
    Klungel, Olaf H.
    Stricker, Bruno H. Ch
    de Boer, Anthonius
    Maitland-van der Zee, Anke-Hilse
    PHARMACOGENETICS AND GENOMICS, 2010, 20 (12): : 766 - 774
  • [3] Progression of coronary calcium and near-term risk of myocardial infarction in patients receiving cholesterol-lowering therapy with statins
    Raggi, P
    Callister, T
    Shaw, L
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 24 - 24
  • [4] Cholesterol-lowering therapy after acute myocardial infarction in a low coronary risk population
    Andrikopoulos, G
    Richter, D
    Zairis, M
    Needham, E
    Grammatopoulos, D
    Foussas, S
    Mattu, R
    Stefanadis, C
    Gialafos, J
    Toutouzas, P
    EUROPEAN HEART JOURNAL, 2000, 21 : 702 - 702
  • [5] EVALUATION OF THE COST-EFFECTIVENESS RATIO OF CHOLESTEROL-LOWERING DRUGS IN SECONDARY PREVENTION OF MYOCARDIAL-INFARCTION
    AURSNES, I
    THORVIK, E
    FORSEN, L
    KRISTIANSEN, IS
    WAALER, HT
    CIRCULATION, 1994, 90 (04) : 362 - 362
  • [6] Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy
    Raggi, P
    Callister, TQ
    Shaw, LJ
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (07) : 1272 - 1277
  • [7] Reducing the risk for stroke in patients with myocardial infarction - A Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy
    Gotto, AM
    Farmer, JA
    CIRCULATION, 2002, 106 (13) : 1595 - 1598
  • [8] The PCSK9 E670G Polymorphism Modifies the Effectiveness of Statins in Reducing the Risk of Myocardial Infarction
    Peters, B. J. M.
    Pett, H.
    de Boer, A.
    Klungel, O. H.
    Maitland-van der Zee, A. H.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S114 - S114
  • [9] Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S) -: Impact of predicted risk on the benefit of cholesterol-lowering treatment
    Wilhelmsen, L
    Pyörälä, K
    Wedel, H
    Cook, T
    Pedersen, T
    Kjekshus, J
    EUROPEAN HEART JOURNAL, 2001, 22 (13) : 1119 - 1127
1